4th Quarter - Report — MEDCO HEALTH SOLUTIONS, INC for MEDCO HEALTH SOLUTIONS INC (2008)

Firm

MEDCO HEALTH SOLUTIONS, INC

Client

MEDCO HEALTH SOLUTIONS INC

Income

—

Expenses

$780,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health Information Technology, Electronic Prescribing, Comparative Effectiveness, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Carve-out of Generic Drugs from State Generic Substituion Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357- Protecting Records, Optimizing Treatment and Easing Communcations through Healthcare Technology PRO(TECH)T Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects

Lobbyist	Covered position, as disclosed
PETER BEGANS	—
ALLYSON BLANDFORD	—
BILL HEAD	—
KIMBERLY LINTHICUM	—
HEATHER STEWART	—

Contacted: Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); SENATE; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP)

Bills named: H.R. 6898 (110th), H.R. 2914 (110th), S. 316 (110th), H.R. 2567 (110th), H.R. 971 (110th), S. 3505 (110th), H.R. 1956 (110th), S. 1814 (110th), H.R. 5629 (110th), H.R. 1432 (110th), H.R. 3800 (110th), H.R. 6357 (110th)

Medicare/Medicaid MMM

Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Competitive Acquuisition Program for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2008; all aspects

Lobbyist	Covered position, as disclosed
PETER BEGANS	—
ALLYSON BLANDFORD	—
BILL HEAD	—
KIMBERLY LINTHICUM	—
HEATHER STEWART	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); SENATE; Food & Drug Administration (FDA); Federal Trade Commission (FTC)

Bills named: H.R. 2567 (110th), H.R. 2914 (110th), H.R. 971 (110th)

Pharmacy PHA

Electronic Prescribing, Electronic Prescribing of Controlled Substances, Antitrust Exemption for Independent Pharmacies HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects

Lobbyist	Covered position, as disclosed
PETER BEGANS	—
ALLYSON BLANDFORD	—
BILL HEAD	—
KIMBERLY LINTHICUM	—
HEATHER STEWART	—

Contacted: Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA)

Bills named: H.R. 971 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.